S&P 500

6.114,63

-0,01%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NYSE
Palantir Technologies Inc (PLTR)
Palantir Technologies Inc (PLTR) Notícias

PLTR

Palantir Technologies (PLTR)

Palantir Technologies Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:PLTR

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
18/07/2013	05:00	GlobeNewswire Inc.	U.S. National Institutes of Health Recommend to Expand Its Scope of Research in the Development of Pluristem's PLX-RAD Cells fo	NYSE:PLTR
11/07/2013	04:00	GlobeNewswire Inc.	Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial	NYSE:PLTR
08/07/2013	04:00	GlobeNewswire Inc.	Pluristem's South Korean Partner Files IND With Korean FDA for PLX Cells	NYSE:PLTR
26/06/2013	04:00	GlobeNewswire Inc.	Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercializa	NYSE:PLTR
20/06/2013	04:00	GlobeNewswire Inc.	Pluristem's Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE	NYSE:PLTR
19/06/2013	10:00	GlobeNewswire Inc.	Pluristem Provides Update on Clinical Status of IC Trials	NYSE:PLTR
10/06/2013	04:00	GlobeNewswire Inc.	Pluristem to Deliver Two Presentations During Israel's Largest Biotech Conference: IATI-BioMed	NYSE:PLTR
04/06/2013	10:00	GlobeNewswire Inc.	Pluristem to Receive Clinical-hold Notice From the U.S. FDA	NYSE:PLTR
29/05/2013	05:00	GlobeNewswire Inc.	Pluristem to Present at FDA Symposium	NYSE:PLTR
22/05/2013	06:30	GlobeNewswire Inc.	Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nucl	NYSE:PLTR
13/05/2013	04:30	GlobeNewswire Inc.	Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia	NYSE:PLTR
07/05/2013	04:00	GlobeNewswire Inc.	Pluristem Develops PLX-RAD Cells for Use in Hematology	NYSE:PLTR
30/04/2013	04:00	GlobeNewswire Inc.	Pluristem to Present at Needham Healthcare and Oppenheimer Israeli Investment Conferences in May 2013	NYSE:PLTR
29/04/2013	04:00	GlobeNewswire Inc.	Third Party Research Study Demonstrates Pluristem's PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension	NYSE:PLTR
18/04/2013	04:00	GlobeNewswire Inc.	Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine	NYSE:PLTR
11/04/2013	04:00	GlobeNewswire Inc.	United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial	NYSE:PLTR
10/04/2013	03:00	GlobeNewswire Inc.	Pluristem Announces Scientific and Investment Conferences for April 2013	NYSE:PLTR
20/03/2013	04:00	GlobeNewswire Inc.	Pluristem Reports on the Progress of Its Phase I/II Clinical Trial for the Treatment of Muscle Injury	NYSE:PLTR
21/02/2013	04:30	GlobeNewswire Inc.	Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia	NYSE:PLTR
13/02/2013	10:56	GlobeNewswire Inc.	CORRECTING AND REPLACING -- Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summ	NYSE:PLTR
13/02/2013	06:00	GlobeNewswire Inc.	Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summit '13	NYSE:PLTR
30/01/2013	06:00	GlobeNewswire Inc.	Pluristem Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility	NYSE:PLTR
22/01/2013	11:00	GlobeNewswire Inc.	Pluristem Updates Cell Manufacturing Industry on Its Proprietary 3D Cell Expansion Technology at Industry Conference	NYSE:PLTR
15/01/2013	07:00	GlobeNewswire Inc.	Pluristem Receives Approval to Expand Its Phase II Clinical Trial in Intermittent Claudication to Germany	NYSE:PLTR
07/01/2013	10:00	GlobeNewswire Inc.	Pluristem's CEO Letter to Shareholders	NYSE:PLTR
27/12/2012	06:00	GlobeNewswire Inc.	Pluristem Initiates Final Validation of New Manufacturing Facility	NYSE:PLTR
12/12/2012	06:00	GlobeNewswire Inc.	Pluristem to Present at Oppenheimer 23rd Annual Healthcare Conference	NYSE:PLTR
04/12/2012	06:00	GlobeNewswire Inc.	Pluristem Advances Its Intramuscular Hematology Program; Assembles Clinical Advisory Board of World Renowned Opinion Leaders	NYSE:PLTR
21/11/2012	09:00	GlobeNewswire Inc.	Pluristem Reports Status of Orphan Drug Application for Aplastic Anemia	NYSE:PLTR
14/11/2012	10:00	GlobeNewswire Inc.	Pluristem to Initiate a Phase I/II Clinical Trial in Muscle Injury	NYSE:PLTR